Table 1.
Demographic and clinical characteristics of IIH patients (n = 139).
| Variables | Mean (range), N (%) |
|---|---|
| Gender | |
| Male | 13 (9.4) |
| Female | 126 (90.6) |
| Age (years) | 32.1 ± 10.8 (12–59) |
| Family history | 4 (2.8) |
| Weight | 85.5 ± 17.2 |
| Height | 162.4 ± 6.9 |
| BMI | |
| <18.5 (underweight) | 0 (0.0) |
| 18.5 to <25 (normal) | 14 (10.1) |
| 25 to <30 (overweight) | 40 (28.8) |
| >30 (obese) | 85 (61.1) |
| Nationality | |
| Kuwaiti | 89 (64.0) |
| Egyptian | 21 (15.1) |
| Indian | 10 (7.2) |
| Others | 29 (20.8) |
| Symptoms at presentation | |
| Headache | 134 (96.4) |
| TVOs | 84 (60.4) |
| Tinnitus | 72(51.8) |
| Diplopia | 22 (15.8) |
| Blurring of vision | 85 (61.2) |
| Other symptoms | 19 (13.7) |
| Signs at presentation | |
| Papilledema (n = 139) | 138 (99.3) |
| Sixth N. (n = 139) | 22 (15.8) |
| Seventh N. (n = 139) | 1(0.7) |
| Risk factors | |
| BMI > 25 | 125 (89.9) |
| No identifiable risk factors | 13 (9.3) |
| Comorbidities | |
| Anemia (n = 139) | 53 (38.1) |
| PCOS (n = 139) | 13 (9.4) |
| OCP (n = 139) | 30 (21.6) |
| Vitamin A (139) | 11 (7.9) |
| Hypertension | 27 (19.4) |
| Diabetes mellitus | 11(7.9) |
| Migraine | 7 (5.0) |
| Hypothyroidism | 6 (4.3) |
| Treatment | |
| Medical treatment | 139 (100) |
| CSF shunt | 5 (3.6) |
| ONSF | 7 (5.0) |
| VSS | 1 (0.7) |
| Bariatric surgery | 10 (7.1) |
Qualitative data were described using number and percent. Normally quantitative data were expressed as mean ± SD. BMI, body mass index; TVOs, transient visual obscuration; PCOS, polycystic ovary syndrome; OCP, oral contraceptive pills; CSF, cerebrospinal fluid; ONSF, optic nerve sheath fenestration; VSS, venous sinus stenting.